Banned Drugs Still Available in Bangladesh after the Declaration of the Regulatory Authority: A Cross Sectional Study Conducted in Chittagong City
[1]
Md. Jakaria, Department of Pharmacy, International Islamic University Chittagong (IIUC), Chawkbazar, Chittagong, Bangladesh.
[2]
Md Ibrahim Tarek, Department of Pharmacy, International Islamic University Chittagong (IIUC), Chawkbazar, Chittagong, Bangladesh.
[3]
Abul Hasanat, Department of Pharmacy, International Islamic University Chittagong (IIUC), Chawkbazar, Chittagong, Bangladesh.
[4]
A. T. M. Mostafa Kamal, Department of Pharmacy, International Islamic University Chittagong (IIUC), Chawkbazar, Chittagong, Bangladesh.
[5]
Mohammed Abu Sayeed, Department of Pharmacy, International Islamic University Chittagong (IIUC), Chawkbazar, Chittagong, Bangladesh.
[6]
Md. Hazrat Ali, Department of Pharmacy, International Islamic University Chittagong (IIUC), Chawkbazar, Chittagong, Bangladesh.
We aimed to determine the proportion of pharmacies in Chittagong that sold the banned drugs and to increase awareness by simple survey study. A cross sectional study of sample of 150 pharmacies was conducted in Chittagong, the city of Bangladesh, in November 2014. The sample was taken randomly from different regions of Chittagong city. A simulated client methodology was used. Data were analyzed using simple statistics. Minimum one drug was available in one hundred thirty six (90.66% & 95% CI= 90.66 ± 4.66) pharmacies. In fourteen pharmacies (9.33% & 95% CI= 9.33 ± 4.65) there no banned drugs were available. From the total pharmacy, one hundred and twenty six pharmacies (84% & 95% CI= 84 ± 5.87) offered fluphenthioxol-melitracin combination tablet. Pioglitazone was offered by sixty six pharmacies (44% & 95% CI= 44 ± 7.94) and sixty two (41.33% & 95% CI= 41.33 ± 7.88) pharmacies offered rosiglitazone. Gatifloxacin as an antibiotic oral tablet was found in seventy four pharmacies (49.33% & 95% CI= 49.33 ± 8). Thirty seven pharmacies (24.66% & 95% CI= 24.66 ± 7.08) offered tegaserod and sibutramine were offered by thirty pharmacies (20% & 95% CI= 20 ± 6.40). In conclusion, the practice of banned drugs was terrifyingly high among the population of Chittagong city. If it is not stops right now in near future there is utmost possibility of ours country people to suffer for a dangerous health disaster. This study has also opened gateways for further research in this issue.
Survey study, pharmacies, banned drug, Chittagong city
[1]
www.forcon.ca,http://www.forcon.ca/learning/drugs.html, Accessed 25 April 2015.
[2]
Rang HP, Dale MM, Ritter JM, Flower RJ, Handerson G. Rang and Dale’s Pharmacology, Elsevier, Edinburgh, London, NewYork, Oxford, Philadelphia, St Louis, Toronto 7th edition, 2012. pp. 1.
[3]
Bertram G. katzung, Susan B. Masters, Anthony J. Trevor. Basic and Clinical Pharmacology., Tata Mc Graw-Hill, New York 11th edition, 2011, pp.67-72.
[4]
Bennett and Brown. Clinical Pharmacology, Churchill Livingstone, New York, U.S.A 10th edition, 2008, pp. 41-60.
[5]
www.centerwatch.com, http://www.centerwatch.com/clinical-trials/overview.aspx Accessed 14 April 2015.
[6]
Biyani D, Agrawal D, Patel S. Availability of Banned drugs: A case Report. International Journal of Pharmaceutical Sciences Review and Research. 2011; 9: 112-113.
[7]
Aronson JK. Medication errors: what they are, how they happen, and how to avoid them. Advance Access Publication. 2009: 102: 513–521.
[8]
Vlahović-Palčevski V, Mentzer D. Postmarketing surveillance. Handb Exp Pharmacol.2011; 205: 339-51.
[9]
medimoon.com, http://medimoon.com/2012/10/list-of-banned-drugs-by-fda/. Accessed 14 April 2015.
[10]
prescriptiondrugs.procon.org, http://prescriptiondrugs.procon.org/view.resource.php?resourceID=005528. Accessed 14 April 2015.
[11]
www.dgda.gov.bd, http://www.dgda.gov.bd/index.php/downloads/directorate-info Accessed 17 April 2015.
[12]
www.dhakatribune.com.http://www.dhakatribune.com/safety/2014/apr/03/ban-6-adverse-drugs-recommended. Accessed 09 Jan 2015.
[13]
Abdulhak AAB, Tannir MAA, Almansor MA et al. Non prescribed sale of antibiotics in Riyadh, Saudi Arabia: A Cross Sectional Study. BMC Public Health. 2011; 11: 538.
[14]
Suvarna DV. “Phase IV of Drug Development.” Perspectives in Clinical Research. 2010; 2(1): 57–60.
[15]
Malhotra K, Goyal M, Walia R, Aslam S. Medication Errors: A Preventable Problem Indian Journal of Clinical Practice. 2012; 23(1):17-21.
[16]
http://buddymd.com.buddymd. side-effects-deanxit-flupentixol-melitracen. Accessed 09 Jan 2015.
[17]
Hashmi A. Pioglitazone suspension and its aftermath: A wake up call for the Indian drug regulatory authorities. Journal of Pharmacology & Pharmacotherapeutics. 2013; 4(4): 227-229.
[18]
Kalra K, Ali N Kumar H. Comparative evaluation of chemical equivalence of some commercially available brands of Gatifloxacin tablet. Int. J. of Pharm. & Life Sci. 2011; 2: 1203-1205.
[19]
Basu S, Verma S. Thin at what cost? Case Reports of Sibutramine-Induced Psychotic Disorders. ASEAN Journal of Psychiatry. 2014; 15 (2): 213-216.
[20]
Gupta M, Ghom A, Debta FM et al. Banned Drugs: Still available in India. Journal of Indian academy of Oral Medicine and Radiology. 2011; 23(3): 380-381.
[21]
Minhaj MA, Ikram M, Waris M. Cardiovascular safety profile of Pioglitazone Along with Vitamin E. Journal of Drug Delivery & Therapeutics. 2013; 3(3): 76-80.
